In the literature, SCA3 or Machado-Joseph disease (MJD) was the first genetically confirmed SCA subtype in a patient with the levodopa-responsive Parkinson disease (PD) like phenotype, although the symptoms of this patient did not exactly resemble idiopathic PD [2]. The gene discussed is ATXN3; the disease is Parkinson disease.